Key result
Unprotected left main DES PCI yields ~20% long-term major cardiovascular events, with EF <=55% predicting worse outcomes.
Observational (n=148)
Answers are grounded in this paper and cite their sources.
Shows acceptable long-term safety and identifies risk predictors after drug-eluting stenting for unprotected left main coronary artery disease, highlighting high-risk clinical subgroups.
AIMS: To evaluate the long-term follow-up of drug-eluting stents (DES) in the treatment of unprotected left main coronary artery (ULMCA). METHODS AND RESULTS: One hundred and forty-eight patients (mean age 71 +/- 10 years) with ULMCA stenoses underwent percutaneous coronary intervention (PCI) with DES. Mean ejection fraction (EF) was 63 +/- 13% and distal ULMCA was involved in 63.5% of cases. In-hospital outcome showed one intra-procedural death, no stent thrombosis and 2% non Q-wave myocardial infarction (MI). Clinical follow-up was available in all patients (874 +/- 382 days): 10.1% of them had died, 8.8% had target lesion revascularisation (TLR) and 4.1% experienced MI. Major adverse cardiac events (MACE) occurred in 20.3%. Mortality predictors were EF < or = 55% (OR 3.6, 95%-C.I. 1.3-10.1, p = 0.016) and EuroSCORE > or = 6 (OR 3.9, 95%-CI 1.1-14.1, p = 0.037). TLR predictors were distal lesion (OR 8.5, 95%-CI 1.1-15, p = 0.041) and age < 64 years (OR 3.1, 95%-CI 1-9, p = 0.042). MACE predictor was EF < or = 55% (OR 2.4, 95%-CI 1.1-5.2, p = 0.027). CONCLUSIONS: ULMCA stenting with DES is safe, with favourable in-hospital outcome. Long-term results are acceptable with a mortality rate of 10%, a TLR rate of 9%, and a MACE rate of 20%. Low EF and high EuroSCORE predict mortality, while younger age and distal lesions predict TLR. Low EF also predicts MACE.
No takes yet. Share an insight, caveat, or question.
Pavei et al. (2009) conducted an observational in Unprotected left main coronary artery (ULMCA) stenosis (n=148). Percutaneous coronary intervention with drug-eluting stents was evaluated on Major adverse cardiac events (MACE). PCI with drug-eluting stents for unprotected left main lesions resulted in 20.3% major cardiovascular events, 10.1% mortality, and 8.8% TLR at 874 days, with EF <=55% predicting major cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: